Vimian Group AB (publ) logo

Vimian Group AB (publ)

SSE:VIMIAN.ST

Overview | Financials
Company Name Vimian Group AB (publ)
Symbol VIMIAN.ST
Currency SEK
Price 29.12
Market Cap 12,936,268,800
Dividend Yield 0%
52-week-range 20.08 - 37.96
Industry Diagnostics & Research
Sector Healthcare
CEO Mr. Alireza Tajbakhsh
Website https://vimian.com

An error occurred while fetching data.

About Vimian Group AB (publ)

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and

Related Stocks

Arjo AB (publ) logo

Arjo AB (publ)

ARJO-B.ST

50.05 SEK

Elekta AB (publ) logo

Elekta AB (publ)

EKTA-B.ST

77.06 SEK

Medicover AB (publ) logo

Medicover AB (publ)

MCOV-B.ST

145.3 SEK

AddLife AB (publ) logo

AddLife AB (publ)

ALIF-B.ST

102 SEK

Swedencare AB (publ) logo

Swedencare AB (publ)

SECARE.ST

60.34 SEK

Biotage AB (publ) logo

Biotage AB (publ)

BIOT.ST

184.3 SEK

Camurus AB (publ) logo

Camurus AB (publ)

CAMX.ST

440 SEK

Synsam AB (publ) logo

Synsam AB (publ)

SYNSAM.ST

45.15 SEK

Vitrolife AB (publ) logo

Vitrolife AB (publ)

VITR.ST

187.4 SEK

Financials

Numbers are in millions USD

Numbers are in millions USD